DS Laboratories Innovates and expands its dermatological reach across the world.

FOR IMMEDIATE RELEASE
Johannesburg, South Africa - November 13, 2025 - DS Laboratories, one of the most famous names in the sphere of dermatological hair and skin care, continues its revolution of the industry with its innovative science-driven formulations and international growth. Through the application of the best nano-technology, DS Laboratory has become associated with clinical excellence, and it has served more than 2 million customers in 50 or more countries.
Since its establishment, DS Laboratories has remained firm in the partnership with leading dermatologists in developing safer and effective solutions for hair thinning, loss, and aging indicators. The entire product lineup of the company has the renowned Revita Hair Density Shampoo which has ingredients such as Nanoxidil, caffeine and botanical extracts. The proprietary Advanced Nanosome Delivery System also stands out as a unique selling point of the brand, providing the active ingredients directly into the scalp to achieve the highest possible effect and visibly improve hair health within several months.
According to a representative of the DS Laboratories, the company bases its success upon the scientific rigor which has provided actual outcomes for customers. We constantly establish the new standards of excellence in the hair and skin care due to our collaborations with the dermatologists and our investment into the breakthrough technologies.
Supported by an open, paper trail method of conducting clinical research, DS laboratories prioritizes customer safety and satisfaction, ensuring its product lines do not include harsh surfactants. The cruelty-free formulas and the dermatologist-approved formulas have assisted the company in achieving a five-star rating among thousands of verified customers, many of whom reported improvements in the density of their hair and overall scalp health after three to six months of using the brand.
The research-based ethos of the company is confirmed by the regular acknowledgment in the industry and the prescriptions given by trichology experts, and Revita Shampoo is listed in the trichology manuals as a therapeutic choice in the treatment of androgenic alopecia. The dedication to clinical development that DS Laboratories has has placed it in the front line of care of a broad range of hair and skin issues.
A dermatology expert contracted by a third party confirms, "DS Laboratories is a leader in personal care innovation based on evidence. Its advanced delivery system and special combinations of ingredients are aimed at addressing not only the symptoms but the cause of hair loss, which makes their formulae a reliable solution to a therapeutic routine."
In the future, DS Laboratories is committed to the future of dermatological science- expanding their research, creating new bioactive compounds and expanding their product line. The mission of the company is plain: change the personal care landscape radically with the technologies and products that are known to make people's lives better at any age.
Having strong partnerships, wide distribution networks and a dogged focus on innovation, DS Laboratories is, therefore, able to deliver evidence-based personal care solutions to healthcare practitioners and consumers globally.
About DS Laboratories
DS Laboratories is an international leader in skin care and dermatological hair care, and it is known for its scientifically based and clinically proven products. Advanced Nanosome Delivery System is one of the innovations that have established a new benchmark in ingredient delivery and therapeutic outcome in the company. In May 2024, DS Laboratories was acquired by Megalabs, adding even greater global capabilities to it. All the products are cruelty-free, dermatologist-approved and designed to address the varied concerns of hair and skin among millions of people across the globe.
Contact:
Email: dslabs@veaudry.com
Website: www.dslaboratories.co.za
Unit D1 The Gantry, Witkoppen Road, Lonehill, Johannesburg, South Africa, 2021